OpenBIO® is transforming bioprocessing efficiency with an open-architecture bioreactor controller that maximizes automation, scalability, and precision. Designed to streamline operations, OpenBIO bioreactor control system empowers users with intelligent control, seamless integration, and remote accessibility—enabling faster innovation and optimized production.
Open. Smart. Scalable.
Why Catalyx is the Partner You Need
Unmatched Bioprocessing Expertise
Rely on a world-class team with decades of experience in biomanufacturing, automation, and mission-critical operations.
Open Innovation, On Your Terms
Enjoy true freedom to innovate—Catalyx’s solutions are never locked down, giving you control over your technology roadmap.
Proven Success, Trusted Support
From deployment to optimization, our experts guide you every step of the way, ensuring your projects stay on track and on time.
The Next Generation of Automation & Controls
| Other Controllers | |||
|---|---|---|---|
| Open – Any counts of devices | Both support any number of devices, but traditional models require complex integration. | ||
| Open – Vessel Agnostic | Traditional systems generally lack vessel agnosticism and require manual configuration. OpenBIO is fully vessel agnostic. | ||
| Open – Multiple DCS | While traditional controllers may be limited to specific DCS systemS, OpenBIO inherently support multiple DCS platforms. | ||
| Open - Any vendor of devices | Traditional controllers often struggle with consistent vendor support, while OpenBIO maintains uniform compatibility across devices from different manufacturers. | ||
| Average Lead Time | Traditional systems often have long lead times, while OpenBIO can be fully integrated within 12–16 weeks. | ||
| Tablet & Browser HMIs | Fixed and proprietary interfaces dominate traditional systems, limiting mobility, while OpenBIO supports tablet and browser-based HMIs for on-the-go monitoring. | ||
| PAT Ready | Traditional controllers often lack direct PAT integration, demanding custom solutions, while OpenBIO comes fully prepared. |
OpenBIO®:
Designed for the Future of Biomanufacturing
Smart, Scalable Automation
Adaptive control reduces downtime, increases efficiency, and lets you scale from a single unit to hundreds—supporting up to 75% more production capacity.
Effortless Integration & Fast Deployment
Easily connect with your existing and future systems—no vendor lock-in. Get up and running in just 12–16 weeks, cutting rollout times by over 50%.
Remote-First & Space-Optimized
Monitor and control operations in real time, from anywhere. Mobile-first, remote access can free up to 400,000 sq. ft. of facility space
Award-Winning Innovation
OpenBIO® received the 2018 Innovator Award from Pharmaceutical Manufacturing Magazine for advancing open-architecture bioprocess control and driving smarter, more flexible manufacturing.
PROCESS & PACKAGING AUTOMATION:
Pharmaceutical Company Achieves Real-Time Bioreactor Control, Reducing Batch Time by 57%
A pharmaceutical company integrated Endress+Hauser Raman analyzers with the Catalyx OpenBIO® Bioreactor Controller to enhance process efficiency. This real-time solution eliminated manual sampling, reduced contamination risks, and cut batch time from seven to three days, achieving an ROI of $300,000 per unit annually.
Read story